pca 4248 has been researched along with Disease Exacerbation in 1 studies
PCA 4248: structure given in first source; platelet activating factor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, TP | 1 |
| Huettner, B | 1 |
| Koefeler, H | 1 |
| Mayer, G | 1 |
| Bambach, I | 1 |
| Wallbrecht, K | 1 |
| Schön, MP | 1 |
| Wolf, P | 1 |
1 other study available for pca 4248 and Disease Exacerbation
| Article | Year |
|---|---|
Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice.
Topics: Animals; Cytokines; Dihydropyridines; Disease Progression; Down-Regulation; Humans; Mice; Mice, Tran | 2011 |